Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotech-bay source : Www.biospace.com save search
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Published: 2024-04-22 (Crawled : 23:00) - biospace.com/
ACET | News | $2.1 5.0% 4.76% 1.1M
|
Health Technology
|
| O: 2.56%
H: 2.0%
C: 0.0%
adi-270 presentation cell preclinical for meeting therapy
Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
Published: 2024-04-22 (Crawled : 23:00) - biospace.com/
SPRB | News | $0.7007 1.26% 1.24% 1M
|
Health Technology
|
| O: -2.86%
H: 2.94%
C: 1.47%
presentation endocrine meeting
New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance
Published: 2024-04-22 (Crawled : 17:00) - biospace.com/
VCYT | News | $19.82 -0.15% -0.15% 560K
|
Health Technology
|
| O: 1.03%
H: 2.65%
C: 1.02%
active test cancer for study
FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
GH | News M | $17.34 -1.42% -1.44% 1.8M
|
Health Services
|
| O: 4.42%
H: 5.36%
C: 4.83%
fda test review cancer blood for
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
TWST | $31.505 6.98% 6.51% 1.1M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
report bioscience financial results
Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024
Published: 2024-04-16 (Crawled : 00:00) - biospace.com/
EXEL | $23.295 1.86% 1.82% 1.9M
|
Health Technology
|
| O: -0.62%
H: 0.0%
C: 0.0%
first financial results
QT Imaging Announces Second Blinded Screening Trial Finding Its Technology Similarly Effective as Digital Breast Tomosynthesis
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
GIA | $1.08 237.96% 1.4K
|
| Email alert
Add to watchlist
breast technology trial imaging
Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
Published: 2024-04-15 (Crawled : 14:00) - biospace.com/
A | $139.2 3.95% -0.14% 2M
|
Health Technology
|
| O: 1.12%
H: 0.66%
C: -1.47%
certification assay for
Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care
Published: 2024-04-15 (Crawled : 14:00) - biospace.com/
OM | $2.46 5.13% 4.88% 640K
|
Health Technology
|
| O: 0.0%
H: 2.93%
C: -0.49%
association care medical
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 11, 2024
Published: 2024-04-11 (Crawled : 07:00) - biospace.com/
MIRM | $24.4 0.95% 0.94% 420K
|
Health Technology
|
| O: -0.35%
H: 1.98%
C: 1.25%
nasdaq pharmaceuticals grants
Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference
Published: 2024-04-09 (Crawled : 14:30) - biospace.com/
VTGN | $4.83 1.05% 1.04% 190K
|
Health Technology
|
| O: 0.58%
H: 3.65%
C: 3.27%
conference association depression
Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-04 (Crawled : 22:00) - biospace.com/
ACLX | $54.43 4.67% 4.46% 410K
|
|
| O: -0.13%
H: 2.16%
C: -1.76%
conference
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
Published: 2024-04-03 (Crawled : 14:00) - biospace.com/
GH | News M | $17.34 -1.42% -1.44% 1.8M
|
Health Services
|
| O: -0.14%
H: 4.43%
C: -5.11%
precision health meeting application
Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-03 (Crawled : 14:00) - biospace.com/
ANNX | $4.46 -1.87% -1.91% 800K
|
Health Technology
|
| O: 0.78%
H: 3.86%
C: -0.31%
conference
Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics
Published: 2024-04-03 (Crawled : 14:00) - biospace.com/
A | $139.2 3.95% -0.14% 2M
|
Health Technology
|
| O: -0.28%
H: 0.75%
C: -0.03%
cancer research diagnostics
Nurix Therapeutics to Participate in Upcoming Investor Conferences - April 03, 2024
Published: 2024-04-03 (Crawled : 12:00) - biospace.com/
NRIX 6 d | $14.125 4.01% 3.86% 690K
|
Health Technology
|
| O: -1.28%
H: 0.68%
C: -0.55%
therapeutics
Infinant Health Announces Submission of Orphan Drug Designation Application
Published: 2024-04-02 (Crawled : 14:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.77%
H: 0.8%
C: 0.74%
drug health designation application submission
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International
Published: 2024-04-02 (Crawled : 14:00) - biospace.com/
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: -4.68%
H: 0.82%
C: 0.82%
health international
Bristol Myers Squibb Releases 2023 Environmental, Social and Governance Report Demonstrating Progress and Setting New Long-Term Goals
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 0.21%
H: 0.47%
C: -0.68%
report
Jaguar Health Reports 2023 Financial Results
Published: 2024-04-01 (Crawled : 18:00) - biospace.com/
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -14.35%
health financial results
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.